For Episode 35, we sit down with Simon Allen, CEO of Anebulo Pharmaceuticals.  Find out how Anebulo is addressing the unmet need for treatment of acute cannabinoid intoxication and other substance use disorders with their innovative novel therapeutics. First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder.  Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.